Rare Brain Disorder Gets Its First FDA Drug Approval

The FDA has approved zilganersen (Zanvastro), the first drug for treating Alexander disease, a rare brain disorder caused by protein buildup.

This Wire brief sits within Fusion42's coverage of Biotech, and 15 sources have reported it between 3 Sep 2026 and 22 Sep 2026.